Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2Not yet recruiting 1

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2Gynecologic 2Genitourinary 2Gastrointestinal 2

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 151Leukemia 138Leukemia, Myeloid, Acute 127Myelodysplastic Syndromes 106Precursor Cell Lymphoblastic Leukemia-Lymphoma 103Lymphoma 87Lymphoma, Non-Hodgkin 86Multiple Myeloma 84Hodgkin Disease 81Lymphoma, Mantle-Cell 71Lymphoma, Follicular 68Lymphoma, Large B-Cell, Diffuse 60Congenital Abnormalities 59Myeloproliferative Disorders 58Lymphoma, B-Cell, Marginal Zone 58Leukemia, Myeloid, Chronic-Phase 56Leukemia, Myelomonocytic, Chronic 52Leukemia, Myeloid, Accelerated Phase 50Burkitt Lymphoma 50Leukemia, Myelogenous, Chronic, BCR-ABL Positive 46Lymphoma, Large-Cell, Immunoblastic 43Anemia, Refractory, with Excess of Blasts 42Waldenstrom Macroglobulinemia 41Blast Crisis 40Primary Myelofibrosis 38Melanoma 35Recurrence 34Neoplasms, Plasma Cell 34Dendritic Cell Sarcoma, Interdigitating 30Lymphoma, T-Cell, Cutaneous 29

Interventions

Radiotherapy 11Cisplatin 11Radiotherapy, Intensity-Modulated 6Radiation 5Fluorouracil 5Cetuximab 5pembrolizumab 4Carboplatin 3fludarabine phosphate 2fludarabine 2durvalumab 2aldesleukin 2Vorinostat 2Surveys and Questionnaires 2Restraint, Physical 2Psychiatric Rehabilitation 2Polymerase Chain Reaction 2Paclitaxel 2Nivolumab 2Nicotine 2Immunohistochemistry 2Hydroxyurea 2Gene Expression Profiling 2Drug Therapy 2Docetaxel 2Cyclophosphamide 2Counseling 2Celecoxib 2Bupropion 2Blood Specimen Collection 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Oropharyngeal Neoplasms × fludarabine phosphate × Clear all
NCT01585428 2018-03-07

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
29 enrolled 12 charts
GastrointestinalGenitourinaryGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Oropharyngeal Neoplasms, Penile Neoplasms, Vaginal Neoplasms, Papillomavirus Infections

NCT02280811 2017-09-06

T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
12 enrolled 19 charts
GastrointestinalGenitourinaryGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Neoplasm Metastasis, Oropharyngeal Neoplasms, Penile Neoplasms, Vaginal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡